Brief: Skye Bioscience Uplists to The Nasdaq Global Market

Skye Bioscience

10/04/2024 13:21

April 10 (Reuters) - Skye Bioscience Inc  SKYE.PK :
    * SKYE BIOSCIENCE INC: COMMON STOCK IS EXPECTED TO COMMENCE
TRADING ON NASDAQ AT MARKET OPEN ON THURSDAY, APRIL 11TH, 2024
    * SKYE BIOSCIENCE INC:  COMMON STOCK IS EXPECTED TO TRADE
UNDER
TICKER SYMBOL "SKYE"
    * SKYE BIOSCIENCE INC: CO'S COMMON STOCK WILL NO LONGER
TRADE ON
OVER--COUNTER SECURITIES MARKET
    * SKYE BIOSCIENCE INC:  EXPECT PHASE 2 CLINICAL TRIAL FOR
OUR
OBESITY-FOCUSED PERIPHERAL CB1 INHIBITOR TO BE LAUNCHED IN Q3
2024."

Source text for Eikon:  ID:nGNX8qphWP 
Further company coverage:  SKYE.PK 

 ((Reuters.Briefs@thomsonreuters.com;))